329 (PB-124) - PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy
| Autor: | Kanaizumi, H., Higashi, C., Tanaka, Y., Hamada, M., Shinzaki, W., Hashimoto, Y., Inui, H., Houjou, T., Komoike, Y. |
|---|---|
| Zdroj: | In European Journal of Cancer April 2018 92 Supplement 3:S91-S91 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect